1. Cell Cycle/DNA Damage Apoptosis Protein Tyrosine Kinase/RTK
  2. IRE1 Apoptosis FGFR
  3. PAIR2

PAIR2 is a highly selective inhibitor targeting the kinase domain of human IRE1α, with a Ki value of 8.8 nM against human IRE1α. PAIR2 fully occupies the ATP-binding site of the IRE1α kinase domain, partially antagonizes the ribonuclease activity of IRE1α, specifically inhibits regulated IRE1α-dependent decay (RIDD) and its mediated substrate cleavage, while preserving the splicing function of Xbp1 mRNA. PAIR2 also promotes the differentiation of B cells into plasma cells, blocks IRE1α-induced cell apoptosis, and restores the expression of Fgfr2 mRNA in AT2 cells. PAIR2 effectively reaches a steady-state concentration in the lung tissues of Mus musculus, and serves as an important tool for investigating the function of the IRE1α signaling pathway in diseases such as pulmonary fibrosis.

For research use only. We do not sell to patients.

PAIR2

PAIR2 Chemical Structure

CAS No. : 2771006-54-1

Size Price Stock Quantity
1 mg Get quote 3 - 5 weeks 2 - 4 weeks 4 - 6 weeks 2 - 4 weeks
5 mg Get quote 3 - 5 weeks 2 - 4 weeks 4 - 6 weeks 2 - 4 weeks
10 mg Get quote 3 - 5 weeks 2 - 4 weeks 4 - 6 weeks 2 - 4 weeks
25 mg Get quote 3 - 5 weeks 2 - 4 weeks 4 - 6 weeks 2 - 4 weeks
50 mg Get quote 3 - 5 weeks 2 - 4 weeks 4 - 6 weeks 2 - 4 weeks
100 mg   Get quote  
200 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 Customer Validation

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PAIR2 is a highly selective inhibitor targeting the kinase domain of human IRE1α, with a Ki value of 8.8 nM against human IRE1α. PAIR2 fully occupies the ATP-binding site of the IRE1α kinase domain, partially antagonizes the ribonuclease activity of IRE1α, specifically inhibits regulated IRE1α-dependent decay (RIDD) and its mediated substrate cleavage, while preserving the splicing function of Xbp1 mRNA. PAIR2 also promotes the differentiation of B cells into plasma cells, blocks IRE1α-induced cell apoptosis, and restores the expression of Fgfr2 mRNA in AT2 cells. PAIR2 effectively reaches a steady-state concentration in the lung tissues of Mus musculus, and serves as an important tool for investigating the function of the IRE1α signaling pathway in diseases such as pulmonary fibrosis[1][2].

IC50 & Target

IRE1α

8.8 nM (Ki)

FGFR2

 

In Vitro

PAIR2 (1-10 μM; 1 h + 6 h doxycycline (HY-N0565)) dose-dependently blocks doxycycline-induced autophosphorylation of IRE1α in INS-1::PCMV/2xTetO cells[1].
PAIR2 (0.5-10 μM; 1 h+2 h DTT (HY-15917)) maintains XBP1 mRNA splicing in parental INS-1 cells subjected to DTT stress[1].
PAIR2 (2 μM; 24 h Thapsigargin (HY-13433)) rescues Fgfr2 mRNA expression in serum-free, feeder-free primary mouse AT2 organoids under Thapsigargin stress, while preserving IRE1α-mediated Xbp1 splicing[2].
PAIR2 (2 μM; 3-d) fails to prevent the conversion of primary serum-free, feeder-free mouse AT2 cells to DATCs when pemigatinib directly blocks the Fgfr signaling pathway[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: INS-1::PCMV/2xTetO rat insulinoma cells (doxycycline-inducible IRE1α overexpression)
Concentration: 1, 3, 10 μM
Incubation Time: 1 h (PAIR2 pre-incubation); 6 h (doxycycline treatment)
Result: Dose-dependently blocked doxycycline-induced IRE1α autophosphorylation, reducing phosphorylated IRE1α levels to near baseline at concentrations ≥3 μM, with equivalent potency to KIRA8.

RT-PCR[1]

Cell Line: parent INS-1 rat insulinoma cells
Concentration: 0.5, 1, 3, 10 μM
Incubation Time: 1 h (PAIR2 pre-incubation); 2 h (DTT treatment)
Result: Preserved DTT-induced XBP1 mRNA splicing at all tested concentrations, with no significant reduction in splicing percentage relative to DTT-only treated cells (all P values > 0.05, non-significant).
In Vivo

Selective inhibition of RIDD with PAIR2 (30 mg/kg; i.p.; twice daily) reduces AT2 cell differentiation into profibrotic transitional cells and protects C57BL/6 mice from Bleomycin (HY-108345)-induced pulmonary fibrosis[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (10-20 week-old, both male and female, bleomycin-induced pulmonary fibrosis)[2]
Dosage: 30 mg/kg
Administration: i.p.; twice daily; starting 1 day before bleomycin exposure and continuing through study end
Result: Reduced fraction of trace+Krt8+ / trace+ cells compared to vehicle control at day 10 post-bleomycin exposure.
Significantly lowered lung hydroxyproline content and reduced fibrillar collagen deposition via picrosirius red staining at day 14 post-bleomycin exposure.
Derepressed expression of canonical RIDD target Bloc1s1 in lung tissue.
Did not significantly affect Xbp1 splicing.
Molecular Weight

590.59

Formula

C27H26F4N6O3S

CAS No.
SMILES

CC(C(F)=C(NS(CC(F)(F)F)(=O)=O)C1=C2C=CC=C1)=C2OC3=NC=CC=C3C4=NC(N[C@H]5CCCNC5)=NC=C4

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PAIR2
Cat. No.:
HY-145425
Quantity:
MCE Japan Authorized Agent: